More articles from Idiopathic interstitial pneumonias

Longitudinal changes in CT quantified pulmonary artery volume and interstitial abnormalities correlate with pulmonary function decline in IPF patients
Anne-Noëlle Frix, Fanny Gester, Monique Henket, Benoit Ernst, Renaud Louis, Jonne Engelberts, Jean-Paul Charbonnier, Julien Guiot

European Respiratory Journal Sep 2023, 62 (suppl 67) PA1134; DOI: 10.1183/13993003.congress-2023.PA1134
Circulating biomarkers in children and adolescents with fibrosing interstitial lung disease (ILD)
Robin Deterding, Kevin K Brown, Steven Cunningham, Emily M Deboer, Matthias Griese, Nicolaus Schwerk, Lisa R Young, Carina Ittrich, Thomas Schlange, Martina Gahlemann, David Warburton

European Respiratory Journal Sep 2023, 62 (suppl 67) PA1146; DOI: 10.1183/13993003.congress-2023.PA1146
Circulating prostasin associates with presence and severity of idiopathic pulmonary fibrosis (IPF)
Jamie Todd, Hillary Mulder, Megan L Neely, John A Belperio, Joseph A Lasky, Tracy R Luckhardt, Scott M Palmer, Christian Hesslinger, Thomas Schlange, Thomas B Leonard

European Respiratory Journal Sep 2023, 62 (suppl 67) PA1144; DOI: 10.1183/13993003.congress-2023.PA1144
Predicting factors of acute exacerbation of idiopathic pulmonary fibrosis
Morgane Browarski, Chloe Rousseau, Pierre Chauvin, Stéphanie Guillot, Mathieu Lederlin, Mallorie Kerjouan, Stéphane Jouneau

European Respiratory Journal Sep 2023, 62 (suppl 67) PA1148; DOI: 10.1183/13993003.congress-2023.PA1148
Lipid metabolism in interstitial lung diseases: serum amyloid A a new potential biomarker in idiopathic pulmonary fibrosis
Lucia Vietri, Miriana D'Alessandro, Laura Bergantini, Paolo Cameli, Elena Bargagli

European Respiratory Journal Sep 2023, 62 (suppl 67) PA1142; DOI: 10.1183/13993003.congress-2023.PA1142
Associations between neutrophil and lymphocyte counts and ILD progression in subjects with progressive fibrosing ILDs
Michael Kreuter, Justin M Oldham, Claudia Valenzuela, Takafumi Suda, Heiko Müller, Kamila Sroka-Saidi, Toby M Maher

European Respiratory Journal Sep 2023, 62 (suppl 67) PA1136; DOI: 10.1183/13993003.congress-2023.PA1136
Serum Krebs von den Lungen-6 (KL-6) level as a prognostic biomarker in patients with interstitial lung abnormalities (ILA)
Hye Kyeong Park, Young-Soon Yoon, Jae-Uk Song, Hyung Koo Kang

European Respiratory Journal Sep 2023, 62 (suppl 67) PA1145; DOI: 10.1183/13993003.congress-2023.PA1145
Blood gene expression is associated with decline in lung function in interstitial lung disease
Daniel He, Boyang Zheng, Scott J Tebbutt, Christopher J Ryerson

European Respiratory Journal Sep 2023, 62 (suppl 67) PA1135; DOI: 10.1183/13993003.congress-2023.PA1135
Clinical utility of heparin-binding protein as an acute-phase inflammatory marker in interstitial lung disease
Mingshan Xue, Teng Zhang, Runpei Lin, Yifeng Zeng, Zhangkai Jason Cheng, Ning Li, Peiyan Zheng, Huimin Huang, Baoqing Sun

European Respiratory Journal Sep 2023, 62 (suppl 67) PA1138; DOI: 10.1183/13993003.congress-2023.PA1138
STING inhibitor ameliorates senescence via inhibiting cGAS-STING pathway in Idiopathic Pulmonary Fibrosis
Lorena Rosas, Natalia-Del Pilar Vanegas, Madeline Riley, Erica L Dale, Victor Peters, Sean D Stacey, Marc Kaestle, Peter Seither, Ana L Mora, Mauricio Rojas

European Respiratory Journal Sep 2023, 62 (suppl 67) OA4199; DOI: 10.1183/13993003.congress-2023.OA4199

Main menu

User menu

Search

More articles from Idiopathic interstitial pneumonias

Pages

Contact us